Federal authorities have announced that they are reviewing the possibility of loosening the classification of marijuana, and if this happens, it could have a far-reaching impact on how the substance is used in medical settings, experts said.

Marijuana is currently classified as a Schedule I drug, meaning it is listed alongside heroin and LSD as among the "most dangerous drugs" and has "no currently accepted medical use and a high potential for abuse."

The Drug Enforcement Administration announced last week that it is reviewing the possibility of reclassifying it as a Schedule II drug, which would put it in the same category as Ritalin, Adderal and oxycodone.

Medical experts are welcoming the review, saying it could ease restrictions for researchers, so that they can better understand which compounds in marijuana could be used to help patients.

Click here to read the complete article

Gillian Mohney ~ AbcNews.com ~

Recent News Articles

Tuesday March 26

Hemp About To Be Removed From Texas’ Controlled Substances List - Cannabis News

in Law & Crime

by Bruce Kennedy - Editor in Chief

The state of Texas is taking a big step toward legitimizing the use of CBD…

835 hits

Tuesday March 26

Flood of products containing cannabis extract puts FDA in a bind - Cannabis News

in CBD & Hemp

by Bruce Kennedy - Editor in Chief

What might have been an FDA attempt to hit the pause button while it sorts…

1020 hits

Tuesday March 26

Mexican Government Launches Poll To Ask Citizens If Marijuana Should Be Legal - Cannabis News

in World News

by Bruce Kennedy - Editor in Chief

A Mexican cabinet official is asking the country’s citizens whether they support legalizing marijuana—in a…

1130 hits

Tuesday March 26

A Beginners Guide To Reading Marijuana Labels - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

The plant has never been more accessible so read up.

1481 hits

Wednesday March 27

Can medicinal cannabis treat the tics in Tourette syndrome? - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

A pioneering clinical trial investigating medicinal cannabis as a potential treatment for people living with…

708 hits